Our Terms of Service and Privacy Policy have changed.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
| 77.38 Delayed Data As of Sep 22 |  +0.06 / +0.08%Today’s Change | 56.59 Today|||52-Week Range 81.87 | +24.71% Year-to-Date |
| Why Is ResMed (RMD) Up 3.1% Since the Last Earnings Report? Sep 11 / Zacks.com - Paid Partner Content |
| Previous close | 77.32 |
| Today’s open | 77.17 |
| Day’s range | 77.12 - 77.60 |
| Volume | 600,244 |
| Average volume (3 months) | 1,047,397 |
| Market cap | $11.0B |
| Dividend yield | 1.81% |
| Earnings growth (last year) | -3.61% |
| Earnings growth (this year) | +17.47% |
| Earnings growth (next 5 years) | +11.56% |
| Revenue growth (last year) | +12.40% |
| P/E ratio | 32.2 |
| Price/Sales | 5.37 |
| Price/Book | 5.61 |
| Today’s change | Today’s % change | |
|---|---|---|
| VARVarian Medical Syste... | +0.56 | +0.54% |
| LIVNLivaNova PLC | +0.82 | +1.19% |
| NVRONevro Corp | +1.44 | +1.67% |
| IRTCIrhythm Technologies... | +2.87 | +5.89% |
| Next reporting date | October 26, 2017 |
| EPS forecast (this quarter) | $0.66 |
| Annual revenue (last year) | $2.1B |
| Annual profit (last year) | $342.3M |
| Net profit margin | 16.56% |
Sector Health Technology |
Industry Medical Specialties |
Chief Executive Officer & Director Mick Farrell |
President & Chief Operating Officer Rob Douglas |
Corporate headquarters San Diego, California |
